Public Company News
Phase 3 Clinical Study of Mazdutide in Chinese Adults with Overweight or Obesity (GLORY-1) Published in The New England Journal of Medicine (NEJM)
SAN FRANCISCO and SUZHOU, China, May 26, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic...
2025-05-26 08:00
4767
EDAN Highlights Commitment to Global Health at GHF 2025 Satellite Symposium, a Side Event of the World Health Assembly
GENEVA, May 25, 2025 /PRNewswire/ -- Edan Instruments, Inc.
2025-05-25 21:41
6117
Mindray Debuts Next-Generation BeneVision V Series Patient Monitoring System at Euroanaesthesia 2025
SHENZHEN, China, May 25, 2025 /PRNewswire/ -- Mindray
2025-05-25 19:00
4387
Soundcore Liberty 5: Revolutionizing Voice-Canceling with Adaptive ANC 3.0 and Dolby Audio
Top 3 Global Wireless Audio Brand[1] Unveils Next-Gen Travel-Ready Earbuds SINGAPORE, May 25, 2025 /PRNewswire/ -- Soundcore, the premium audio brand under Anker Innovations and ranked third globally in wireless headphone shipments, today launched its groundbreaking product, the Liberty 5 in Si...
2025-05-25 14:00
4499
COMPUTEX 2025: MiTAC Powers Sustainable AI Data Centers with New Server & Cooling Tech
TAIPEI, May 24, 2025 /PRNewswire/ -- At COMPUTEX 2025, MiTAC Computing Technology Corp., a subsidiary of MiTAC Holdings Corp. (TWSE: 3706), unveiled its bold new vision: from hardware provider to full-solution AI and data center innovator. With future-ready solutions covering AI training and infe...
2025-05-24 14:52
6491
Celltrion's YUFLYMA® (adalimumab-aaty) receives FDA interchangeability designation for all its approved dosage forms and strengths
* YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar[1] * Celltrion previously received interchangeability (IC) designation for YUFLYMA® (adalimumab-aaty) in prefilled syringes (20mg & 80mg); Expanded interchangeabilit...
2025-05-24 01:47
4873
/DISREGARD RELEASE: Celltrion/
We are advised by Celltrion that journalists and other readers should disregard the news release, Celltrion's YUFLYMA® (adalimumab-aaty) receives FDA interchangeability designation for all its approved dosage forms and strengths, issued21-May-2025 over PR Newswire. ...
2025-05-24 00:01
5035
TWSC Debuts at COMPUTEX 2025: Empowering AI with Full-Stack Storage Solutions
TAIPEI, May 23, 2025 /PRNewswire/ -- From May 20 to 23, 2025, TWSC
2025-05-23 22:08
7650
Mabwell Announces Clinical Data of Multiple ADCs to be presented at 2025 ASCO Annual Meeting
SHANGHAI, May 23, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced multiple clinical research results to be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, including phase Ib/II clini...
2025-05-23 22:00
4783
Tongcheng Travel 2025Q1 Secures Foothold in the Mass Travel Market Revenue Grows 13.2% Yoy to RMB4.4 Billion
Rising Travel Spending Boosts Core OTA Business Growth AI Empowers High-Quality Development Across the Travel Industry Chain HONG KONG, May 23, 2025 /PRNewswire/ -- Tongcheng Travel Holdings Limited ("Tongcheng Travel" or the "Company", together with its subsidiaries the "Group", stock code: 0...
2025-05-23 21:13
7745
NYSE Content Advisory: Pre-Market update + Hinge Health, MNTN pop double digits in trading debuts
NEW YORK, May 23, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Kristen Scholer delivers the pre-market update on May 23rd * Dig...
2025-05-23 20:55
5545
WGC2025 | ENN Leverages "Intelligence + Low Carbon" to Pioneer a New Paradigm for Sustainable Energy Development
LANGFANG, China, May 23, 2025 /PRNewswire/ -- From May 19 to 23, 2025, the 29th World Gas Conference (WGC2025), hosted by the International Gas Union (IGU), convened inBeijing. As the premier global event in the energy sector, WGC2025 attracted leading companies and industry experts from around t...
2025-05-23 20:00
4548
Eason Technology Limited Receives Notification from NYSE Regarding Delayed Form 20-F Filing
HONG KONG, May 23, 2025 /PRNewswire/ -- Eason Technology Limited ("Eason
Technology" or the "Company") (NYSE:DXF
2025-05-23 18:30
6440
Six Abstracts of Kelun-Biotech's Clinical Studies Published at the 2025 ASCO Annual Meeting
CHENGDU, China, May 23, 2025 /PRNewswire/ -- The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting is scheduled to take place in Chicago, Illinois, USA from May 30 to June 3. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK, the "Company") will present results from six cl...
2025-05-23 17:24
5505
Tuniu Announces Receipt of Minimum Bid Price Notice from Nasdaq
NANJING, China, May 23, 2025 /PRNewswire/ -- Tuniu Corporation (Nasdaq: TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company inChina, today announced that it has received written notification from the staff of the Listing Qualifications Department of the Nasdaq Stock Market L...
2025-05-23 17:00
4878
MINISO Group Announces March Quarter 2025 Unaudited Financial Results
Revenue grew 18.9 % year over year Significant sequential improvement of same-store sales(1) in MINISO mainland China for March Quarter Gross margin reached 44.2%, up 0.8 ppt year over year Adjusted EBITDA increased 7.5% year over year to RMB1,037.3 million Shareholder returns reached around RM...
2025-05-23 16:33
8827
England's NICE recommends FILSPARI® (sparsentan) as a treatment option for IgA nephropathy
First non-immunosuppressive dual-action therapy recommended by NICE for eligible patients with IgA nephropathy, a leading cause of kidney failure1-3 NICE's recommendation is based on clinically meaningful results from the phase-III PROTECT trial4 ST. GALLEN, Switzerland, May 23, 2025 /PRNewswi...
2025-05-23 16:16
5025
Antengene to Present Latest Clinical Results from Two Studies in CPI-resistant Solid Tumors at ASCO 2025
* ATG-037, an oral small molecule CD73 inhibitor, in combination with MSD's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), achieved an overall response rate (ORR) of 36.4% and disease control rate (DCR) of 100% in checkpoint inhibitor (CPI)-resistant melanoma patients in the ongoing STAMINA-01 t...
2025-05-23 12:31
5336
Everest Medicines Announces NEFECON® Inclusion in China's Clinical Practice Guideline for IgA Nephropathy and IgA Vasculitis in Chinese Adults (For Public Review)
SHANGHAI, May 23, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics,announced that NEFECON® has been included in the "Clin...
2025-05-23 11:39
3383
ThunderSoft Showcases Japan-Focused Smart Vehicle Solutions at Automotive Engineering Exposition 2025 Yokohama
YOKOHAMA, Japan, May 22, 2025 /PRNewswire/ -- May 21–23, 2025,ThunderSoft, a global leader in intelligent automotive software, made its debut at the Automotive Engineering Exposition 2025 Yokohama (Booth No. 2-249), presenting its next-generation smart vehicle solutions tailored for the Japanese m...
2025-05-23 10:50
6137
Week's Top Stories
Most Reposted
DBS crowned Southeast Asia's most valuable brand in Kantar BrandZ 2026 ranking
[Picked up by 304 media titles]
2026-07-15 12:00
A New Chapter Beckons: Four Seasons Resorts of Asia Celebrates Parenthood with Babymoon Offerings
[Picked up by 295 media titles]
2026-07-10 13:30
Gnomey Hollows Opens at PARKROYAL COLLECTION Marina Bay, Singapore, Extending the Hotel's Gnome-Themed Family Experience
[Picked up by 289 media titles]
2026-07-13 11:42
NCS launches enterprise AI platforms and products; deepens partnerships to accelerate AI-driven business transformation
[Picked up by 288 media titles]
2026-07-09 08:00Tetra Pak Introduces Industry-first Carton Packaging for Shelf-stable Tuna to Support Southeast Asia's Growing Tuna Industry
[Picked up by 285 media titles]
2026-07-13 10:00
Most Read
NYSE Content Update: Samos Energy Acquisition to Make NYSE Debut
2026-07-10 21:04
9174
Elong Power Holding Limited Announces Pricing of US$6.6 Million Public Offering
2026-07-10 20:30
8989
Amcor expands packaging facility in China
2026-07-09 22:48
8291
